![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | May 2024
The Regulator has issued its DB Funding Statement, which is aimed primarily at schemes with valuation dates between September 22, 2023, and September 21, 2024, or “Tranche 19 schemes”. However, the statement is also relevant for schemes which have been significantly impacted by the “changes in market conditions” in recent years, and therefore need to review their investment strategy.
The key points are:
The new funding regulations and DB code will apply to schemes with effective valuation dates from September 22, 2024, onwards, so this is the last funding statement from the Regulator under the current regime.
The Regulator’s Corporate Plan for the next three years was published on May 3, 2024. The Plan sets out the Regulator’s vision to drive forward a raft of measures including scheme preparation for pensions dashboards, the value for money framework, the new DB funding regime and scheme consolidation.
Another key plank of the Regulator’s vision for the next three years is to raise the standards of trusteeship by ensuring trustees have an effective system of governance. This includes developing a framework for the oversight of professional trustee firms, along with a trustee register.
In the second and third years of the Plan, the Regulator will focus on collaboration with the industry and Government to progress the recently proposed solution for deferred small pot consolidation.
The Regulator has laid out an ambitious schedule for the near future and the Plan details how it will address the current challenges to protect savers, enhance the pension system and support innovation.
Our May briefing will take an in-depth look at this year’s funding statement, as well as the Corporate Plan.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Over the past two years, Spain has significantly strengthened its foreign investment screening mechanism, and all acquisitions by foreign investors (as defined below) of a Spanish entity active in a strategic sector are subject to prior authorisation by the Ministry of Industry, Commerce and Tourism (“MoICT”).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023